公司資料
Galecto 股價、新聞與催化劑
- 股票代碼:
- GLTO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Denmark
股價為何變動
目前無法取得 GLTO 的收盤價變動背景。
公司概覽
業務概覽
Galecto is a biotechnology company focused on fibrotic disease and oncology biology. Its platform has been shaped by the challenge of turning a narrow biology story into durable value.
所在地與產業分類
Headquartered in Denmark and listed on NASDAQ as an ADR, Galecto has a global specialty-biotech profile.
商業模式特徵
The company depends on clinical data, target validation, and the ability to create a fibrosis or oncology franchise.
生技產業定位
Galecto is a high-uncertainty biotech name whose valuation is sensitive to pipeline progress.
未來催化劑
- Galecto’s catalysts are fibrosis and oncology updates, with any strategic step important because the company has been in a reset posture. The market wants to know what remains of the pipeline.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。